BCM
BML Capital Management Portfolio holdings
AUM
$131M
This Quarter Return
-23.11%
1 Year Return
+89.45%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$124M
AUM Growth
+$124M
(-23%)
Cap. Flow
-$2.83M
Cap. Flow
% of AUM
-2.29%
Top 10 Holdings %
Top 10 Hldgs %
86.46%
Holding
31
New
6
Increased
8
Reduced
3
Closed
4
Top Buys
| 1 |
THRD
Third Harmonic Bio
THRD
|
$13.3M |
| 2 |
LAVA Therapeutics
LVTX
|
$2.49M |
| 3 |
Adverum Biotechnologies
ADVM
|
$2.07M |
| 4 |
Kezar Life Sciences
KZR
|
$1.75M |
| 5 |
ELEV
Elevation Oncology
ELEV
|
$1.53M |
Top Sells
Sector Composition
| 1 | Healthcare | 98.84% |
| 2 | Technology | 1.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
HilleVax
HLVX
$105M
| $30.1K | 0.02% |
20,760
| – | – |
|
|
ACHL
27
DELISTED
Achilles Therapeutics plc American Depositary Shares
ACHL
| $0 | ﹤0.01% |
3,804,921
-295,081
| -7% | – |
|
|
KLRS
28
Kalaris Therapeutics, Inc. Common Stock
KLRS
$85.5M
| – | – |
-184,246
| Closed | -$77.4K |
|
|
PVLA
29
Palvella Therapeutics, Inc. Common Stock
PVLA
$592M
| – | – |
-42,130
| Closed | -$506K |
|
|
LENZ
30
LENZ Therapeutics
LENZ
$1.12B
| – | – |
-9,271
| Closed | -$268K |
|
31
iShares 0-3 Month Treasury Bond ETF
SGOV
$56B
| – | – |
-260,000
| Closed | -$26.1M |
|